JCI - A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy
PD-1/PD-L1 inhibitors treatment in lung cance | EurekAlert!
Cancers | Free Full-Text | Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations | Journal for ImmunoTherapy of Cancer | Full Text
Definition of immune checkpoint inhibitor - NCI Dictionary of Cancer Terms - National Cancer Institute
Definition of immune checkpoint inhibitor - NCI Dictionary of Cancer Terms - National Cancer Institute
Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review)
IJMS | Free Full-Text | Possibilities of Improving the Clinical Value of Immune Checkpoint Inhibitor Therapies in Cancer Care by Optimizing Patient Selection | HTML
Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action | Immunotherapy
Cancer immunotherapy and the PD-1/PD-L1 checkpoint pathway | Abcam
Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway | Acta Pharmacologica Sinica
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy | Molecular Cancer | Full Text
Frontiers | Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer | Oncology
Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway: Trends in Molecular Medicine
Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer - ScienceDirect
Biomarkers of response to PD-1 pathway blockade | British Journal of Cancer
Mechanism of action of PD-1 and PD-L1 inhibitors. The programmed cell... | Download Scientific Diagram
Rationale for PD-L1 Expression as a Biomarker in Immuno-Oncology
Frontiers | PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake | Pharmacology
Mechanism of action of PD-1 and PD-L1 inhibitors. Tumor cells develop... | Download Scientific Diagram
Immune-related adverse events of checkpoint inhibitors | Nature Reviews Disease Primers
researchopenworld.com
Frontiers | Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors | Cell and Developmental Biology
